Foresite Capital Management I, LLC
Insider CIK 1581219 · AMBI 10% owner · TXG 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| TXG 10x Genomics, Inc. | S Sale | 2020-05-13 | 2020-05-14 | 650,000 | $80.13 | $52.08M | 2,350,000 | SEC↗ |
| TXG 10x Genomics, Inc. | S Sale | 2020-05-13 | 2020-05-14 | 800,000 | $80.13 | $64.10M | 3,500,000 | SEC↗ |
| TXG 10x Genomics, Inc. | C Conversion deriv | 2020-05-12 | 2020-05-14 | 1,930,198 | — | $0 | 0 | SEC↗ |
| TXG 10x Genomics, Inc. | C Conversion | 2020-05-12 | 2020-05-14 | 1,930,198 | — | $0 | 4,300,000 | SEC↗ |
| TXG 10x Genomics, Inc. | C Conversion deriv | 2020-05-06 | 2020-05-08 | 500,000 | — | $0 | 1,930,198 | SEC↗ |
| TXG 10x Genomics, Inc. | C Conversion deriv | 2020-05-06 | 2020-05-08 | 1,500,000 | — | $0 | 3,153,528 | SEC↗ |
| TXG 10x Genomics, Inc. | C Conversion | 2020-05-06 | 2020-05-08 | 1,500,000 | — | $0 | 3,000,000 | SEC↗ |
| TXG 10x Genomics, Inc. | C Conversion | 2020-05-06 | 2020-05-08 | 500,000 | — | $0 | 2,369,802 | SEC↗ |
| TXG 10x Genomics, Inc. | C Conversion deriv | 2020-04-23 | 2020-04-24 | 1,000,000 | — | $0 | 2,430,198 | SEC↗ |
| TXG 10x Genomics, Inc. | C Conversion | 2020-04-23 | 2020-04-24 | 1,000,000 | — | $0 | 1,869,802 | SEC↗ |
| TXG 10x Genomics, Inc. | J Other | 2020-04-22 | 2020-04-24 | 700,000 | — | $0 | 869,802 | SEC↗ |
| TXG 10x Genomics, Inc. | J Other | 2020-04-22 | 2020-04-24 | 178,584 | — | $0 | 178,584 | SEC↗ |
| TXG 10x Genomics, Inc. | J Other | 2020-04-22 | 2020-04-24 | 178,584 | — | $0 | 0 | SEC↗ |
| TXG 10x Genomics, Inc. | J Other | 2020-04-22 | 2020-04-24 | 92,258 | — | $0 | 327,383 | SEC↗ |
| TXG 10x Genomics, Inc. | C Conversion deriv | 2020-04-14 | 2020-04-15 | 1,500,000 | — | $0 | 4,653,528 | SEC↗ |
| TXG 10x Genomics, Inc. | C Conversion | 2020-04-14 | 2020-04-15 | 1,500,000 | — | $0 | 1,500,000 | SEC↗ |
| TXG 10x Genomics, Inc. | J Other | 2020-04-13 | 2020-04-15 | 109,849 | — | $0 | 235,125 | SEC↗ |
| TXG 10x Genomics, Inc. | J Other | 2020-04-13 | 2020-04-15 | 788,317 | — | $0 | 1,569,802 | SEC↗ |
| TXG 10x Genomics, Inc. | J Other | 2020-04-13 | 2020-04-15 | 21,686 | — | $0 | 21,686 | SEC↗ |
| TXG 10x Genomics, Inc. | J Other | 2020-04-13 | 2020-04-15 | 21,686 | — | $0 | 0 | SEC↗ |
| TXG 10x Genomics, Inc. | J Other | 2020-04-13 | 2020-04-15 | 201,115 | — | $0 | 0 | SEC↗ |
| TXG 10x Genomics, Inc. | J Other | 2020-04-13 | 2020-04-15 | 201,115 | — | $0 | 201,115 | SEC↗ |
| TXG 10x Genomics, Inc. | J Other | 2020-04-13 | 2020-04-15 | 433,725 | — | $0 | 0 | SEC↗ |
| TXG 10x Genomics, Inc. | C Conversion deriv | 2020-03-24 | 2020-03-26 | 2,170,619 | — | $0 | 3,430,198 | SEC↗ |
| TXG 10x Genomics, Inc. | C Conversion | 2020-03-24 | 2020-03-26 | 2,170,619 | — | $0 | 2,358,119 | SEC↗ |
| TXG 10x Genomics, Inc. | J Other | 2020-03-18 | 2020-03-19 | 241,619 | — | $0 | 0 | SEC↗ |
| TXG 10x Genomics, Inc. | J Other | 2020-03-18 | 2020-03-19 | 241,619 | — | $0 | 241,619 | SEC↗ |
| TXG 10x Genomics, Inc. | J Other | 2020-03-18 | 2020-03-19 | 947,079 | — | $0 | 187,500 | SEC↗ |
| TXG 10x Genomics, Inc. | J Other | 2020-03-18 | 2020-03-19 | 125,276 | — | $0 | 125,276 | SEC↗ |
| TXG 10x Genomics, Inc. | S Sale | 2020-03-17 | 2020-03-19 | 250,000 | $59.00 | $14.75M | 433,725 | SEC↗ |
| TXG 10x Genomics, Inc. | S Sale | 2020-03-17 | 2020-03-19 | 500,000 | $59.00 | $29.50M | 1,134,579 | SEC↗ |
| TXG 10x Genomics, Inc. | C Conversion deriv | 2020-03-04 | 2020-03-19 | 1,447,079 | — | $0 | 5,600,817 | SEC↗ |
| TXG 10x Genomics, Inc. | C Conversion deriv | 2020-03-04 | 2020-03-19 | 683,725 | — | $0 | 6,153,528 | SEC↗ |
| TXG 10x Genomics, Inc. | C Conversion | 2020-03-04 | 2020-03-19 | 1,447,079 | — | $0 | 1,634,579 | SEC↗ |
| TXG 10x Genomics, Inc. | C Conversion | 2020-03-04 | 2020-03-19 | 683,725 | — | $0 | 683,725 | SEC↗ |
| TXG 10x Genomics, Inc. | C Conversion deriv | 2019-09-16 | 2019-09-16 | 1,324,195 | — | $0 | 0 | SEC↗ |
| TXG 10x Genomics, Inc. | C Conversion deriv | 2019-09-16 | 2019-09-16 | 5,513,058 | — | $0 | 0 | SEC↗ |
| TXG 10x Genomics, Inc. | C Conversion deriv | 2019-09-16 | 2019-09-16 | 6,837,253 | — | $0 | 6,837,253 | SEC↗ |
| TXG 10x Genomics, Inc. | C Conversion deriv | 2019-09-16 | 2019-09-16 | 1,002,166 | — | $0 | 0 | SEC↗ |
| TXG 10x Genomics, Inc. | C Conversion deriv | 2019-09-16 | 2019-09-16 | 5,487,470 | — | $0 | 0 | SEC↗ |
| TXG 10x Genomics, Inc. | C Conversion deriv | 2019-09-16 | 2019-09-16 | 7,047,896 | — | $0 | 7,047,896 | SEC↗ |
| TXG 10x Genomics, Inc. | C Conversion deriv | 2019-09-16 | 2019-09-16 | 558,260 | — | $0 | 0 | SEC↗ |
| TXG 10x Genomics, Inc. | P Buy | 2019-09-12 | 2019-09-16 | 187,500 | $39.00 | $7.31M | 187,500 | SEC↗ |
| AMBI AMBIT BIOSCIENCES CORP | P Buy | 2013-06-24 | 2013-10-16 | 4,817 | $6.77 | $32.6K | 2,079,569 | SEC↗ |
| AMBI AMBIT BIOSCIENCES CORP | P Buy | 2013-06-14 | 2013-10-16 | 7,500 | $7.46 | $56.0K | 2,074,752 | SEC↗ |
| AMBI AMBIT BIOSCIENCES CORP | P Buy | 2013-06-12 | 2013-10-16 | 5,700 | $7.45 | $42.5K | 2,067,252 | SEC↗ |
| AMBI AMBIT BIOSCIENCES CORP | P Buy | 2013-06-03 | 2013-10-16 | 10,000 | $6.99 | $69.9K | 2,061,552 | SEC↗ |
| AMBI AMBIT BIOSCIENCES CORP | P Buy | 2013-05-22 | 2013-10-16 | 5,005 | $6.74 | $33.7K | 2,051,552 | SEC↗ |
| AMBI AMBIT BIOSCIENCES CORP | P Buy | 2013-05-21 | 2013-10-16 | 1,811 | $6.84 | $12.4K | 2,046,547 | SEC↗ |
| AMBI AMBIT BIOSCIENCES CORP | P Buy | 2013-05-20 | 2013-10-16 | 8,120 | $6.90 | $56.0K | 2,044,736 | SEC↗ |
| AMBI AMBIT BIOSCIENCES CORP | P Buy | 2013-05-17 | 2013-10-16 | 36,616 | $6.77 | $247.9K | 2,036,616 | SEC↗ |